Amputation trends among people who use drugs in the context of Philadelphia’s increasingly xylazine adulterated drug supply
The odds of receiving an amputation among individuals with an ICD-10 F11 code rose alongside increased presence of xylazine in the drug supply. As xylazine continues to spread throughout the United States, health providers need more information to better address risk factors for amputation and develop protocols to decrease incidence of PWUO leaving before treatment completion.
Authors
- Sara Beachy (ORCID: https://orcid.org/0000-0002-7467-2075)
- Monika Pogorzelska‐Maziarz (ORCID: https://orcid.org/0000-0002-3449-9722)
- Traci C. Green (ORCID: https://orcid.org/0000-0001-9105-6904)
- Kristin L. Rising (ORCID: https://orcid.org/0000-0003-3882-4956)
- Jeffrey Hom (ORCID: https://orcid.org/0000-0002-2252-9082)
- Megan K. Reed (ORCID: https://orcid.org/0000-0002-4367-7076)
- Rose Laurano
Institutions
- Thomas Jefferson University (US)
- Brown University (US)
- Jefferson College of Health Sciences (US)
- San Francisco Department of Public Health (US)
- Behavioral Health Services (US)
- Jefferson College (US)
Publication Details
- Journal
- Drug and Alcohol Dependence
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1016/j.drugalcdep.2025.112826
- Citations
- 1
- Primary Topic
- Veterinary Pharmacology and Anesthesia
- Type
- article
- Field-Weighted Citation Impact
- 2.35
Funders
- U.S. Department of Health and Human Services
- Health Resources and Services Administration
- National Institute on Drug Abuse
- National Institute of General Medical Sciences